# Efficacy and Safety of Long-term Oral Staphylococcus Albicans Tablets in Patients With Bronchiectasis

> **NCT05407792** · NA · RECRUITING · sponsor: **Qianfoshan Hospital** · enrollment: 134 (estimated)

## Conditions studied

- Bronchiectasis

## Interventions

- **DRUG:** Staphylococcus and Neisseria Tablets
- **OTHER:** On-demand treatment

## Key facts

- **NCT ID:** NCT05407792
- **Lead sponsor:** Qianfoshan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-06
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 134 (ESTIMATED)
- **Last updated:** 2025-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05407792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05407792, "Efficacy and Safety of Long-term Oral Staphylococcus Albicans Tablets in Patients With Bronchiectasis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05407792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*